1291 results found
Initiated by a NHMRC Project Grant in 2014, Professor Danielle Mazza’s (Monash University) journey towards creating the SPHERE Centre of Research Excellence (CRE) has gone from strength to strength in the years following. SPHERE’s mission, focused on fundamental reproductive rights, aims to drive better sexual and reproductive health outcomes for Australian women through primary care.
Questions and answers from the Ideas Grants 2025 peer reviewer webinar. Recorded 22 July 2025.
Drinking alcohol in pregnancy can harm the unborn child and may cause a range of neurodevelopmental disorders including Fetal Alcohol Spectrum Disorder (FASD).1
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
Worldwide, pneumonia is a leading cause of childhood death. About one-third of these deaths could be prevented by using the pneumococcal conjugate vaccine (PCV). Most of these deaths occur in low- and middle-income countries (LMICs) that have not made full use of PCV, both because of its high cost and uncertainty about impact. Researchers at the University of Melbourne (UoM) and Murdoch Children’s Research Institute (MCRI) and their international partners have taken major steps towards making PCV more accessible globally.
Enabling Initiatives are foundational efforts that create the conditions for success and will support outcomes across all 5 Focus Areas.
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
Leukaemia is the most diagnosed cancer in children and the second most common cancer causing death among children in Australia.1 NHMRC-funded researchers at the Children’s Cancer Institute (CCI), in collaboration with researchers at Flinders University and in European laboratories, developed a highly accurate and sensitive technique – known as minimal residual disease (MRD) testing – that enables doctors to improve anti-cancer treatment for children with the most common type of leukaemia.
The Health Translation South Australia is an NHMRC-accredited Research Translation Centre. We collaborate to deliver research-informed healthcare and training. The below case studies highlight our work in translating research into better health outcomes and building capability across the system.
Haemolytic disease of the fetus and newborn (HDFN, also known as Rh Disease) can occur during pregnancy when a pregnant woman’s immune system produces antibodies that attack their fetus’ red blood cells (RBCs). Once a major cause of fetal and newborn mortality, today HDFN is almost non-existent in Australia due to routine antenatal blood grouping and antibody screening, and the use of prophylactic Rh D immunoglobulin and appropriate clinical management of mother and baby. Guidelines, initially produced by NHMRC on behalf of the Department of Health and Ageing, have assisted with translation of the research on Rh D antibody screening and Rh D immunoglobin into clinical practice.